The MOSFARM company is recalling a batch of the antibiotic Linezolid.

MOSCOW, September 7 - RIA Novosti. The pharmaceutical company MOSFARM decided to withdraw a batch of the antibiotic Linezolid from circulation due to non-compliance with safety criteria, according to a document from Roszdravnadzor, which was reviewed by RIA Novosti.

Linezolid is an antibiotic that belongs to a new class of antimicrobial agents - oxazolidinones. It acts on bacteria in a unique way, so there is no cross-resistance with other classes of antibiotics.

“The Federal Service for Surveillance in Healthcare informs about the decision taken by the manufacturer, MOSFARM LLC, to recall from circulation the drug “Linezolid, solution for infusion 2 mg/ml 300 ml, bottles (15), cardboard boxes” series 0150526 due to the non-compliance of the batch of this series of the drug with the established requirements for the indicator “Bacterial endotoxins,” the document says.

The “Bacterial endotoxins” indicator is a critically important safety criterion, primarily for drugs that are administered parenterally to the body (injections, infusions). It allows you to normalize the content of pyrogenic impurities - substances that can cause a febrile reaction in a person (increase in temperature).